1. Baldwin, R. W., 1982, Manipulation of host resistance in cancer therapy.Springer Seminars in Immunopathology,5, 113–125.
2. Chedid, L., 1983, Muramyl peptides as possible endogenous immunopharmacological mediators.Microbiology and Immunology,27, 723–732.
3. Collet, B., Martin, A., Le Garrec, Y., Dubray, G., andToujas, L., 1983, Antitumor activity of cell walls fromBruceila abortus.Journal of the National Cancer Institute,71, 529–534.
4. Fidler, I. J., Barnes, Z., Fogler, W. E., Kirsh, R., Bugelski, P., andPoste, G., 1982, Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.Cancer Research,42, 496–501.
5. Gouguel, A. F., Lespinats, G., andNauciel, C., 1982, Peptidoglycans extracted from Gram-positive bacteria: expression of antitumor activity according to peptide structure and route of injection.Journal of the National Cancer Institute,68, 657–663.